RIGL - Rigel pharmaceuticals targets $200M-$210M revenue in 2025 with strong Q1 performance
2025-05-06 23:14:22 ET
More on Rigel Pharmaceuticals
- Rigel Pharmaceuticals, Inc. (RIGL) Q1 2025 Earnings Call Transcript
- Rigel Pharmaceuticals: 3-Drug Company Reaches Profitability
- Rigel Looks Interesting, But Let's Wait For A Lower Price
- Rigel Pharmaceuticals Q1 2025 Earnings Preview
- Rigel settles patent litigation regarding its immune thrombocytopenia treatment